Williams D W, Bartie K L, Potts A J, Wilson M J, Fardy M J, Lewis M A
Department of Oral Surgery, Medicine and Pathology, Dental School, University of Wales College of Medicine, Cardiff, United Kingdom.
Gerodontology. 2001 Dec;18(2):73-8. doi: 10.1111/j.1741-2358.2001.00073.x.
The aim of this study was to assess persistence and tissue invasion of Candida albicans strains isolated from a 65 year-old patient with chronic hyperplastic candidosis (CHC), that subsequently developed into squamous cell carcinoma (SCC).
C. albicans (n=7) were recovered from the oral cavity of the patient over seven years. Confirmation of CHC and SCC in this patient was achieved by histopathological examination of incisional biopsy tissue. DNA fingerprinting was performed on the seven isolates from the CHC patient together with a further eight isolates from patients with normal oral mucosa (n=2), chronic atrophic candidosis (n=1), SCC (n=1) and CHC (n=4). Genotyping involved the use of inter-repeat PCR using the eukaryotic repeat primer 1251. Characterisation of the tissue invasive abilities of the isolates was achieved by infecting a commercially available reconstituted human oral epithelium (RHE; SkinEthic, Nice, France). After 24 h, C. albicans tissue invasion was assessed by histopathological examination.
DNA fingerprinting demonstrated strain persistence of C. albicans in the CHC patient over a seven year period despite provision of systemic antifungal therapy. The strain of C. albicans isolated from this patient was categorised as a high invader within the RHE compared to other isolates.
Candidal strain persistence was evident in a patient with CHC over seven years. This persistence may be due to incomplete eradication from the oral cavity following antifungal therapy or subsequent recolonisation from other body sites or separate exogenous sources. The demonstration of enhanced in vitro tissue invasion by this particular strain may, in part, explain the progression to carcinoma.
本研究旨在评估从一名65岁慢性增生性念珠菌病(CHC)患者分离出的白色念珠菌菌株的持续性及组织侵袭情况,该患者随后发展为鳞状细胞癌(SCC)。
在七年时间里从该患者口腔中分离出7株白色念珠菌。通过对切开活检组织进行组织病理学检查确诊该患者患有CHC和SCC。对来自CHC患者的7株分离株以及另外8株来自正常口腔黏膜患者(n = 2)、慢性萎缩性念珠菌病患者(n = 1)、SCC患者(n = 1)和CHC患者(n = 4)的分离株进行DNA指纹分析。基因分型采用真核重复引物1251进行重复序列间PCR。通过感染市售的重组人口腔上皮(RHE;SkinEthic,法国尼斯)来评估分离株的组织侵袭能力。24小时后,通过组织病理学检查评估白色念珠菌的组织侵袭情况。
DNA指纹分析表明,尽管给予了全身抗真菌治疗,但白色念珠菌菌株在该CHC患者体内持续存在了七年。与其他分离株相比,从该患者分离出的白色念珠菌菌株在RHE中被归类为高侵袭性菌株。
CHC患者体内白色念珠菌菌株持续存在达七年之久。这种持续性可能是由于抗真菌治疗后口腔内未被彻底清除,或随后从身体其他部位或不同外源重新定植所致。该特定菌株体外组织侵袭能力增强的表现可能部分解释了其向癌症的进展。